Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
FDF
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. Alevaire
2. Enuclene
3. Formaldehyde, Polymer With Oxirane And 4-(1,1,3,3-tetramethylbutyl)phenol
4. Oxyethylated Tertiary Octylphenol Formaldehyde Polymer
5. P-isooctylpolyoxyethylenephenol Formaldehyde Polymer
6. Polyhydroxyethyl-tert-octylphenolformaldehyde
7. Superinone
8. Supervent
9. Translight
10. Triton A 20
11. Triton Wr 1339
12. Triton Wr-1339
13. Tyloxapol
14. Tyroxapol
15. Wr-1339
1. Tyloxapol
2. 25301-02-4
3. Tyloxypal
4. Triton Wr-1339
5. Superinone
6. Alevaire
7. Nsc90255
8. Formaldehyde;oxirane;4-(2,4,4-trimethylpentan-2-yl)phenol
9. Triton A-20
10. Formaldehyde, Polymer With Oxirane And4-(1,1,3,3-tetramethylbutyl)phenolother Ca Index Names:oxirane, Polymer With Formaldehyde And4-(1,1,3,3-tetramethylbutyl)phenolphenol, 4-(1,1,3,3-tetramethylbutyl)-, Polymer With Formaldehyde Andoxirane
11. Superiuone
12. Component Of Alevaire
13. Formaldehyde; Oxirane; 4-(1,1,3,3-tetramethylbutyl)phenol
14. Schembl181284
15. Dtxsid30179950
16. Chebi:141517
17. Nsc-90255
18. Akos026749862
19. Formaldehyde,1,3,3-tetra Methylbutyl)phenol
20. Ab01563398_01
21. Q7860340
22. Ethoxylated P-tert-octylphenol Formaldehyde Polymer
23. Wln: /qr Dx1&1&1x1&1&1/ &/*o2*/ &/*o1*/
24. Phenol,1,3,3-tetramethylbutyl)-, Polymer With Ethylene Oxide And Formaldehyde
Molecular Weight | 280.4 g/mol |
---|---|
Molecular Formula | C17H28O3 |
Hydrogen Bond Donor Count | 1 |
Hydrogen Bond Acceptor Count | 3 |
Rotatable Bond Count | 3 |
Exact Mass | 280.20384475 g/mol |
Monoisotopic Mass | 280.20384475 g/mol |
Topological Polar Surface Area | 49.8 Ų |
Heavy Atom Count | 20 |
Formal Charge | 0 |
Complexity | 204 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 3 |
Tyloxapol is an inhaled surfactant that assists in removing and liquefying and removing bronchopulmonary secretions with mucus and pus. Tyloxapol is administered either through nebulized solution or a stream of oxygen. Also investigated for use/treatment in cystic fibrosis and pediatric indications.
It is used as a surfactant to aid liquefaction and removal of mucopurulent (containing mucus and pus) bronchopulmonary secretions. Tyloxapol also blocks plasma lipolytic activity, and thus the breakdown of triglyceride-rich lipoproteins.
Surface-Active Agents
Agents that modify interfacial tension of water; usually substances that have one lipophilic and one hydrophilic group in the molecule; includes soaps, detergents, emulsifiers, dispersing and wetting agents, and several groups of antiseptics. (See all compounds classified as Surface-Active Agents.)
Detergents
Purifying or cleansing agents, usually salts of long-chain aliphatic bases or acids, that exert cleansing (oil-dissolving) and antimicrobial effects through a surface action that depends on possessing both hydrophilic and hydrophobic properties. (See all compounds classified as Detergents.)
R - Respiratory system
R05 - Cough and cold preparations
R05C - Expectorants, excl. combinations with cough suppressants
R05CA - Expectorants
R05CA01 - Tyloxapol
Tyloxapol, when injected IP, blocks plasma lipolytic activity, and thus the breakdown of triglyceride-rich lipoproteins. It has also been shown to be inhibitor of lipoprotein lipase, thus preventing triglyceride uptake.
Market Place
Reply
11 Sep 2021
Reply
01 Feb 2016
Reply
27 Oct 2015
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
LOOKING FOR A SUPPLIER?